China Cure: Inside the Geopolitics of Health Innovation with Dr Ruby Wang

GWA was proud to host a book discussion in London featuring China Cure: The Rise of a Biotech, AI Medicine and Global Health Superpower by Dr Ruby Wang, GWA’s 2025 Health Innovation Fellow. Generously hosted by Baroness Mary Goudie, the event explored how China's rapid ascent in health tech has moved far beyond public health to become a central pillar of modern geopolitical competition. 

The discussion dove deep into the complex factors reshaping global health dynamics, including:

• The Frontier of Health Innovation: How China is developing an increasingly leading edge in biotech and AI medicine, transforming its domestic system and driving a massive, tech-driven global health footprint.

• US-China Relations: Washington’s security concerns and the strategic implications of legislative shifts like the Biosecure Act, shifting regulatory landscapes, and targeted tariffs on the pharmaceutical industry, including supply chain challenges and macroeconomic trade-offs facing global pharma.

• Global South Dynamics: How China's delivery of affordable biomedical innovations, mobile health platforms, and digital infrastructure across the Global South is transforming traditional development assistance and health equity.

Why GWA is investing in leaders like Dr. Ruby Wang:

Elevating promising, rising leaders is at the very core of GWA’s mission. By championing globally minded leaders with deeply grounded, lived perspectives, GWA brings indispensable clarity to the complex, high-stakes challenges of frontier economics. Dr. Wang’s unique insights perfectly bridge the gap between technical healthcare innovation and macroeconomic strategy—providing the precise roadmap leaders need to navigate the future of the global economy.

Learn more and order your copy here: https://www.amazon.com/China-Cure-Biotech-Medicine-Superpower/dp/1788219546